“Clock stop” time in European Medicines Agency drug reviews accounts for the biggest difference between US and European review duration, according to a recent study published in the Annals of Internal Medicine.
The findings provide support for European Union reform proposals that could reduce the “clock stop” periods when drug evaluation is...








